One Digital Thread. From Molecule to Market.
Stop fragmenting your research across disconnected tools and manual spreadsheets. HubMed provides a unified AI platform for the R&D lifecycle, ensuring total data continuity from Adam (In-silico Discovery) to Medea (Clinical Compliance). Eliminate data silos and build an audit-proof foundation for your innovation.
Bridging the Divide Between Lab and Audit
Traditional R&D is often bottlenecked by a lack of continuity between early discovery and clinical documentation. HubMed solves this by creating a "secure vault" where your scientific evidence evolves alongside your product.
Seamless Data Transition
Move from preclinical molecule screening straight into Clinical Evaluation Reports without losing a single data point.
Unified Source of Truth
Centralize your discovery data, literature surveillance, and SOTA analysis in one defensible platform.
Audit-Proof Data Continuity
Replace manual "Excel + Word" workflows with a digital audit trail that satisfies Notified Body scrutiny.
A Lifecycle Built for Regulatory Excellence
HubMed's modular architecture is designed to support you at every milestone of the 7-step conformity assessment
Phase 1: Adam (Discovery)
Identify innovative bioactive compounds through intelligent in-silico screening and toxicological safety profiling.
Phase 2: Medea (Compliance)
Transition discovery data into automated CERs and SOTA analysis using the PICO framework.
Phase 3: Market Readiness
Generate NB-ready documentation and technical files that prevent costly "clock-stops" and submission rejections.
Platform Consolidation for the Modern Enterprise
Integration is not just about technology; it is about protecting your revenue and reputation.
70% Reduction in Timelines
By eliminating manual rework and document preparation, you bring products to market faster than ever.
Mitigate Certification Risk
Avoid the €500K–€2M monthly revenue loss associated with failed audits and incomplete technical files.
Scale Without Complexity
Empower your R&D team to handle 200+ linked documents for high-risk devices with automated precision
Frequently asked questions
Here are some common questions about the Integrated Ecosystem.
Notified Bodies now demand digital traceability. If your clinical claims cannot be traced back to the original evidence source with locked versioning and electronic signatures, your submission is at risk of rejection.
Yes. HubMed is a modular ecosystem. You can solve your immediate regulatory needs with Medea and integrate Adam discovery as your R&D strategy expands.
HubMed’s "Brain" machine-reads thousands of scientific publications. By integrating this across the ecosystem, the same evidence appraisal used for discovery inform your clinical evaluation, saving weeks of manual labor.
Ready to Unify Your R&D Lifecycle?
Join the future of ingredient innovation and regulatory excellence with the only unified AI platform built for non-pharma life sciences.